Public statement on the use of herbal medicinal products containing toxic, unsaturated pyrrolizidine alkaloids (PAs) (November 24, 2014). EMA/HMPC/893108/2014, final version - EMA (European Medicines Agency)
Accessed October 12, 2021 at: